Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Radiology ; 265(3): 893-901, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22996749

ABSTRACT

PURPOSE: To evaluate the midterm clinical and angiographic outcomes after pipeline embolization device (PED) placement for treatment of intracranial aneurysms. MATERIALS AND METHODS: This prospective nonrandomized multicenter study was approved by the review boards of all involved centers; informed consent was obtained. Patients (143 patients, 178 aneurysms) with unruptured saccular or fusiform aneurysms or recurrent aneurysms after previous treatment were included and observed angiographically for up to 18 months and clinically for up to 3 years. Study endpoints included complete aneurysm occlusion; neurologic complications within 30 days and up to 3 years; clinical outcome of cranial nerve palsy after PED placement; angiographic evidence of occlusion or stenosis of parent artery and that of occlusion of covered side branches at 6, 12, and 18 months; and clinical and computed tomographic evidence of perforator infarction. RESULTS: There were five (3.5%) cases of periprocedural death or major stroke (modified Rankin Scale [mRS] > 3) (95% confidence interval [CI]: 1.3%, 8.4%), including two posttreatment delayed ruptures, two intracerebral hemorrhages, and one thromboembolism. Five (3.5%) patients had minor neurologic complications within 30 days (mRS = 1) (95% CI: 1.3%, 8.4%), including transient ischemic attack (n = 2), small cerebral infarction (n = 2), and cranial nerve palsy (n = 1). Beyond 30 days, there was one fatal intracerebral hemorrhage and one transient ischemic attack. Ten of 13 patients (95% CI: 46%, 93.8%) completely recovered from symptoms of cranial nerve palsy within a median of 3.5 months. Angiographic results at 18 months revealed a complete aneurysm occlusion rate of 84% (49 of 58; 95% CI: 72.1%, 92.2%), with no cases of parent artery occlusion, parent artery stenosis (<50%) in three patients, and occlusion of a covered side branch in two cases (posterior communicating arteries). Perforator infarction did not occur. CONCLUSION: PED placement is a reasonably safe and effective treatment for intracranial aneurysms. The treatment is promising for aneurysms of unfavorable morphologic features, such as wide neck, large size, fusiform morphology, incorporation of side branches, and posttreatment recanalization, and should be considered a first choice for treating unruptured aneurysms and recurrent aneurysms after previous treatments. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120422/-/DC1.


Subject(s)
Embolization, Therapeutic/instrumentation , Intracranial Aneurysm/diagnostic imaging , Intracranial Aneurysm/therapy , Postoperative Complications/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Cerebral Angiography , Chi-Square Distribution , Female , Humans , Logistic Models , Magnetic Resonance Angiography , Male , Middle Aged , Postoperative Complications/epidemiology , Prospective Studies , Treatment Outcome
2.
J Stroke Cerebrovasc Dis ; 21(8): 915.e11-5, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22459904

ABSTRACT

Cerebral venous thrombosis is an uncommon condition with difficulties in diagnosis and treatment. There is limited study on the best treatment option for this disease. The mainstay of treatment remains systemic anticoagulation with a lengthy duration of warfarin, which has a troublesome unpredictable drug effect, various drug and food interactions, and an increased risk of bleeding. Recent availability of direct thrombin inhibitor provides an alternative option of systemic anticoagulation in various thromboembolism conditions. We report 2 cases of cerebral venous thrombosis treated with a direct thrombin inhibitor with good clinical and radiologic results.


Subject(s)
Antithrombins/therapeutic use , Benzimidazoles/therapeutic use , Intracranial Thrombosis/drug therapy , Venous Thrombosis/drug therapy , beta-Alanine/analogs & derivatives , Adult , Cerebral Angiography/methods , Dabigatran , Humans , Intracranial Thrombosis/diagnosis , Magnetic Resonance Angiography , Male , Middle Aged , Off-Label Use , Phlebography/methods , Treatment Outcome , Venous Thrombosis/diagnosis , beta-Alanine/therapeutic use
3.
AJR Am J Roentgenol ; 182(3): 803-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14975989

ABSTRACT

OBJECTIVE: Tumor thickness in oral tongue cancer is an important independent prognostic factor for local recurrence, nodal metastasis, and patient survival. An accurate preoperative assessment of tumor thickness is therefore essential for optimal treatment planning. The aim of our study was to evaluate the accuracy of MRI findings for the preoperative measurement of tumor thickness. SUBJECTS AND METHODS. Eighteen patients with oral tongue cancer underwent preoperative MRI of the tongue. After surgery, the glossectomy specimens were serially sectioned. The radiologic tumor thickness of contrast-enhanced T1-weighted and T2-weighted images was compared with the histologic tumor thickness using our proposed tumor thickness staging classifications. These included stage I (tumor < or = 3 mm), stage II (> 3 mm but < or = 9 mm) and stage III (> 9 mm). RESULTS: The overall accuracy in assessment of proposed tumor thickness staging using contrast-enhanced T1-weighted and T2-weighted images was 83% and 56%, respectively. The radiologic tumor thickness as measured on contrast-enhanced T1-weighted and T2-weighted images had significant correlation with histologic tumor thickness (R = 0.938 and 0.941, respectively). CONCLUSION: MR images provide satisfactory accuracy for the measurement of tumor thickness and staging of oral tongue cancer. Preoperative MRI is recommended to assist in treatment planning for patients with this disease.


Subject(s)
Carcinoma, Squamous Cell/pathology , Magnetic Resonance Imaging , Tongue Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/surgery , Female , Humans , Linear Models , Male , Middle Aged , Neoplasm Staging , Patient Care Planning , Prospective Studies , Tongue Neoplasms/surgery
4.
J Endovasc Ther ; 11(1): 53-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14748628

ABSTRACT

PURPOSE: To investigate the immediate and midterm results of carotid stenting for severe radiation-induced extracranial carotid artery disease. METHODS: Between April 1998 and May 2002, 16 patients (15 men; mean age 64 +/- 8 years, range 48-72) presented with 18 severe radiation-induced carotid stenoses in the internal carotid artery (n=3), common carotid artery (n=7), and both vessels (n=8). Thirteen (76%) patients were symptomatic; the mean degree of carotid stenosis was 85% +/- 10% (range 70%-95%). An independent neurological specialist assessed perioperative neurological complications before and after treatment. The patients were followed prospectively for at least 12 months by clinical examination and serial duplex ultrasound scanning. Restenosis was defined as a diameter reduction >50%. RESULTS: Of 18 stent procedures attempted (2 staged), 1 was abandoned owing to failure to pass the guidewire across a tight lesion (94% technical success by intent to treat). In the 17 successfully completed procedures, 17 Wallstents and 4 SMART stents were deployed with satisfactory anatomical results. One postoperative stroke occurred as a result of thromboembolism to the ipsilateral middle cerebral artery and led to hospital death (5.9% combined stroke and death rate). One transient ischemic attack occurred (11.6% neurological event rate). With a median 30-month follow-up (range 5-55), 3 (17.6%) recurrent stenoses (>50%) were detected on duplex scan; 1 repeat angioplasty was performed. No new neurological event has been detected. CONCLUSIONS: Carotid stenting may be performed in patients with irradiation-induced carotid stenosis with acceptable risks and midterm durability.


Subject(s)
Carotid Stenosis/therapy , Aged , Carotid Artery, Common , Carotid Artery, Internal , Carotid Stenosis/diagnostic imaging , Female , Humans , Laryngeal Neoplasms/radiotherapy , Male , Middle Aged , Nasopharyngeal Neoplasms/radiotherapy , Radiography, Interventional , Radiotherapy/adverse effects , Ultrasonography, Interventional
5.
Stroke ; 34(5): 1194-6, 2003 May.
Article in English | MEDLINE | ID: mdl-12690213

ABSTRACT

BACKGROUND: The one third middle cerebral artery territory ((1/3) MCA) method and the Alberta Stroke Program Early CT Score (ASPECTS) were used to detect significant early ischemic changes (EIC) on CT brain of acute stroke patients. We sought to compare the reliability of the 2 methods in routine clinical practice. METHODS: Eighty consecutive patients admitted to a community hospital in Hong Kong with suspected acute ischemic stroke and a CT brain scan performed within 6 hours of symptom onset were included. Five blinded observers (1 neurologist, 2 general radiologists, and 2 neuroradiologists) independently evaluated the scans, using the ATLANTIS/CT Summit criteria for >(1/3) MCA involvement, and ASPECTS (1/3) MCA involvement, all observers agreed in 57 cases (71%), with moderate interobserver agreement (kappa=0.49). For ASPECTS

Subject(s)
Brain Ischemia/diagnostic imaging , Severity of Illness Index , Acute Disease , Aged , Aged, 80 and over , Brain Ischemia/drug therapy , Brain Ischemia/epidemiology , Cohort Studies , Female , Hong Kong/epidemiology , Humans , Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/drug therapy , Infarction, Middle Cerebral Artery/epidemiology , Ischemic Attack, Transient/diagnostic imaging , Ischemic Attack, Transient/drug therapy , Ischemic Attack, Transient/epidemiology , Male , Middle Aged , Observer Variation , Predictive Value of Tests , Prevalence , Prospective Studies , Radiography , Reproducibility of Results , Single-Blind Method , Thrombolytic Therapy , Time Factors
6.
Pediatr Radiol ; 32(1): 59-66, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11819066

ABSTRACT

BACKGROUND: It is recognised that the clinical and radiological spectrum of childhood acute disseminated encephalomyelitis (ADEM) is wide. OBJECTIVE: To determine whether initial MRI features are predictive of clinical outcome and to determine the role of MRI in the management of ADEM. MATERIALS AND METHODS: The MRI scans of ten consecutive children (eight boys, two girls), clinically and radiologically diagnosed to have ADEM, were retrospectively reviewed. Follow-up MRI was available for eight patients. RESULTS: Lesions ranged from small and punctate (<1 cm) to moderate sized and confluent (4-5 cm) to diffuse and extensive. Spinal cord lesions, seen in five of seven children, were contiguous or segmental. Seven children (70%) made good clinical recovery while three children (30%) remained severely handicapped. There was no correlation between the site, extent and pattern of involvement and clinical outcome. However, the evolution of MRI findings on follow-up correlated well with the subsequent clinical course and outcome. CONCLUSIONS: Although the extent and site of lesions on initial MRI scans are not predictive of clinical outcome, early MRI of the brain and spine is useful in aiding clinical diagnosis, and subsequent follow-up MRI is helpful in monitoring disease progression.


Subject(s)
Brain/pathology , Encephalomyelitis, Acute Disseminated/pathology , Magnetic Resonance Imaging , Spinal Cord/pathology , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Predictive Value of Tests , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...